Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Helicobacter pylori growth and viability refers to the survival and replication of the H. pylori bacterium, a Gram-negative pathogen that colonizes the human stomach. This is not a specific molecular target but a physiological endpoint used to evaluate the efficacy of eradication therapies. H. pylori is the primary cause of chronic gastritis and peptic ulcer disease and is a major risk factor for gastric adenocarcinoma and MALT lymphoma (NIH, 2023). The bacterium maintains its viability in the acidic gastric environment through the production of urease, which generates a protective ammonia cloud (PubMed, 2022). Clinical treatment typically involves "triple" or "quadruple" therapy regimens consisting of multiple antibiotics and an acid-suppressing agent like a proton pump inhibitor (StatPearls, 2023). Monitoring growth and viability through diagnostic tests is crucial for confirming infection and ensuring successful treatment, especially given the rising rates of antibiotic resistance.
Inhibition of bacterial cell wall synthesis, protein synthesis, and DNA integrity, often combined with gastric acid suppression to enhance antimicrobial activity (StatPearls, 2023).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Helicobacter pylori growth and viability (H. pylori growth).